Hope for New Test, Treatment for Endometriosis

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 11, 2024.

By Dennis Thompson HealthDay Reporter

FRIDAY, Oct. 11, 2024 -- Endometriosis could be linked to the health of a woman’s microbiome, a new study says.

The discovery might help lead to an early test for the painful condition, and possible new treatments.

A specific set of bacteria in women’s gut microbiome appear to be unique among those with endometriosis, a condition that occurs when tissue similar to the lining of the womb grows on other parts of the body, researchers found.

Researchers specifically found that a lack of a bacterial byproduct called 4-hydroxyindole is linked to an increased risk of endometriosis.

“This compound is produced by ‘good bacteria,’ but there is less of it in women with endometriosis than in women without the condition,” lead researcher Chandni Talwar, a postdoctoral associate with the Baylor College of Medicine, said in a news release.

The results indicate that stool tests might help predict a woman’s risk of endometriosis, researchers said.

Further, doctors might be able to treat the condition by altering a woman’s microbiome or treating her with dietary supplements, they added.

Giving 4-hydroxyindole to lab mice prevented endometriosis or warded off the progression of inflammation and pain associated with the condition, researchers report in the journal Med.

“Our study is the first to discover a unique metabolite profile linked to human endometriosis, which brings us closer to better understanding the human condition and potentially identifying better ways to manage it,” Talwar said.

Endometriosis is a painful condition that affects nearly 200 million women worldwide, researchers said in background notes.

“Endometriosis develops when lining inside the womb grows outside its normal location, for instance attached to surrounding intestine or the membrane lining the abdominal cavity,” senior researcher Rama Kommagani, an associate professor of pathology and immunology at Baylor, said in a news release. “This typically causes bleeding, pain, inflammation and infertility.

Based on these findings, researchers now are working on a stool test for endometriosis.

“Generally, it takes approximately seven years to detect endometriosis and is often diagnosed incorrectly as a bowel condition,” Kommagani said. “Thus, delayed diagnosis, together with the current use of invasive diagnostic procedures and ineffective treatments underscore the need for improvements in the management of endometriosis.”

The researchers also are evaluating the safety and effectiveness of 4-hydroxyindole as a potential treatment for endometriosis.

“Interestingly, our findings also may have implications for another condition. The metabolite profile we identified in endometriosis is similar to that observed in inflammatory bowel disease, revealing intriguing connections between these two conditions,” Kommagani said. “Our findings support a role for the microbiome in endometriosis and IBD.”

Sources

  • Baylor College of Medicine, news release, Oct. 11, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-10-12 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords